Steg PG - Search Results

1

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.

Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Hagström E, et al. Among authors: steg pg. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30. Circulation. 2022. PMID: 35770629 Free PMC article. Clinical Trial.

2

Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction.

Feldman LJ, Coste P, Furber A, Dupouy P, Slama MS, Monassier JP, Tron C, Lafont A, Faraggi M, Le Guludec D, Dubois-Randé JL, Steg PG; FRench Optimal STenting-2 Invest. Feldman LJ, et al. Among authors: steg pg. Circulation. 2003 Jun 3;107(21):2684-9. doi: 10.1161/01.CIR.0000070423.91346.45. Epub 2003 May 12. Circulation. 2003. PMID: 12742980 Clinical Trial.

3

Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]).

Goldberg RJ, Currie K, White K, Brieger D, Steg PG, Goodman SG, Dabbous O, Fox KA, Gore JM. Goldberg RJ, et al. Among authors: steg pg. Am J Cardiol. 2004 Feb 1;93(3):288-93. doi: 10.1016/j.amjcard.2003.10.006. Am J Cardiol. 2004. PMID: 14759376

4

Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events.

Brieger D, Eagle KA, Goodman SG, Steg PG, Budaj A, White K, Montalescot G; GRACE Investigators. Brieger D, et al. Among authors: steg pg. Chest. 2004 Aug;126(2):461-9. doi: 10.1378/chest.126.2.461. Chest. 2004. PMID: 15302732

5

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.

Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Röther J, Wilson PW; REACH Registry Investigators. Bhatt DL, et al. Among authors: steg pg. JAMA. 2006 Jan 11;295(2):180-9. doi: 10.1001/jama.295.2.180. JAMA. 2006. PMID: 16403930

6

Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.

Danchin N, Cucherat M, Thuillez C, Durand E, Kadri Z, Steg PG. Danchin N, et al. Among authors: steg pg. Arch Intern Med. 2006 Apr 10;166(7):787-96. doi: 10.1001/archinte.166.7.787. Arch Intern Med. 2006. PMID: 16606817

7

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.

Montalescot G, White HD, Gallo R, Cohen M, Steg PG, Aylward PE, Bode C, Chiariello M, King SB 3rd, Harrington RA, Desmet WJ, Macaya C, Steinhubl SR; STEEPLE Investigators. Montalescot G, et al. Among authors: steg pg. N Engl J Med. 2006 Sep 7;355(10):1006-17. doi: 10.1056/NEJMoa052711. N Engl J Med. 2006. PMID: 16957147 Free article. Clinical Trial.

8

Clinical end points in coronary stent trials: a case for standardized definitions.

Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Cutlip DE, et al. Among authors: steg pg. Circulation. 2007 May 1;115(17):2344-51. doi: 10.1161/CIRCULATIONAHA.106.685313. Circulation. 2007. PMID: 17470709

9

Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry).

Steinberg BA, Steg PG, Bhatt DL, Fonarow GC, Zeymer U, Cannon CP; REACH Registry Investigators. Steinberg BA, et al. Among authors: steg pg. Am J Cardiol. 2007 May 1;99(9):1212-5. doi: 10.1016/j.amjcard.2006.12.039. Epub 2007 Mar 16. Am J Cardiol. 2007. PMID: 17478144

10

Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan.

Yamazaki T, Goto S, Shigematsu H, Shimada K, Uchiyama S, Nagai R, Yamada N, Matsumoto M, Origasa H, Bhatt DL, Steg PG, Ikeda Y; REACH Registry Investigators. Yamazaki T, et al. Among authors: steg pg. Circ J. 2007 Jul;71(7):995-1003. doi: 10.1253/circj.71.995. Circ J. 2007. PMID: 17587702 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,185 results

Search Page